Views: 1,330 | Downloads:
22
| Responses: 0
| XML | Respond to this article | Alert & updates | Request permissions | Email to a friend |
Original ArticleOpen Access
The Efficacy of Terbutaline and Magnesium Sulfate in the Management of Preterm Labor
Surichamom P 
Ninety-six patients with preterm labor at 28 weeks to 35 weeks gestation were
randomized to terbutaline or magnesium sulfate untill 36 weeks gestation, 25 patients were
excluded from the study. Of the remaining 71 patients, 35 patients received terbutaline and
36 patients received magnesium sulfate. The result of the study showed that, there were
no significant differences
(P
>
0.05)
regarding time to stop, mean gestational age at delivery,
time gained, failure rate, time to recurrent labor and readmission for recurrent labor, birth
weight, apgar score and fetal survival. Serious maternal side effects were not observed
with terbutaline or magnesium sulfate, although the majority of women also received
dexamethasone. Neither drug caused serious adverse neonatal effects.
Key word : Terbutaline, Magnesium Sulfate, Preterm Labor
randomized to terbutaline or magnesium sulfate untill 36 weeks gestation, 25 patients were
excluded from the study. Of the remaining 71 patients, 35 patients received terbutaline and
36 patients received magnesium sulfate. The result of the study showed that, there were
no significant differences
(P
>
0.05)
regarding time to stop, mean gestational age at delivery,
time gained, failure rate, time to recurrent labor and readmission for recurrent labor, birth
weight, apgar score and fetal survival. Serious maternal side effects were not observed
with terbutaline or magnesium sulfate, although the majority of women also received
dexamethasone. Neither drug caused serious adverse neonatal effects.
Key word : Terbutaline, Magnesium Sulfate, Preterm Labor
Download:
PDF